FH and coronary artery disorder: It has been demonstrated that patients who are FH causal variant-positive have a significantly increased cardiovascular risk compared to patients who are FH variant-negative with the same LDL-C levels, and it has also been indicated that across various ranges of observed LDL-C levels, the risk of coronary artery disease (CAD) is elevated in FH mutation carriers in comparison to noncarriers [3].